InvestorsHub Logo
Followers 137
Posts 5060
Boards Moderated 0
Alias Born 01/31/2012

Re: Farmer7 post# 1432

Sunday, 04/01/2018 8:40:24 PM

Sunday, April 01, 2018 8:40:24 PM

Post# of 3854
Yes, sir.

Since they're clearly waiting to update us until after their SEC Filing.. This is from their website: https://www.intivabiopharma.com/drug-development-projects

INTELLECTUAL PROPERTY

INTIVA has licensed the intellectual property, including various existing patent applications for the use of cannabinoids and terpenes for exposure to nerve agents.

INTIVA has filed five provisional patents with the United States Patent and Regulatory Office (USPTO), all related to its drug development projects, specifically the use of cannabinoid receptor modulators and/or terpenes to treat certain diseases or medical conditions.

Current Business Activities

INTIVA has initiated formulation work with an Illinois-based pharmaceutical laboratory for the formulation of its nerve agent product. The Company is also now proceeding with identifying the appropriate compounds for its myotonic and muscular diseases drug candidate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NXEN News